循环生长差异化因子-15和糖尿病之间的剂量反应关系:系统性审查和元分析
Jianshu Gao1, Hongli Liu2, Zhongwei Zhou3
1Department of Cardiology, The Yancheng Clinical College of Xuzhou Medical University, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
较高的生长差异化因子-15 (GDF-15) 水平与糖尿病患病率的增加有关. 这种关系是非线性的,在一定GDF-15度后,患病率趋于平稳或略有下降.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 生物标志物研究 生物标志物研究
背景情况:
- 循环生长分化因子-15 (GDF-15) 与不良的临床结果有关.
- 关于GDF-15与糖尿病风险之间的关系的数据有限.
研究的目的:
- 量化评估循环GDF-15与糖尿病患病率之间的关联.
- 评估GDF-15水平与糖尿病风险之间的剂量反应关系.
主要方法:
- 一项对PubMed,Embase和Web of Science数据库研究的元分析,截至2024年4月.
- 纳入标准要求至少有三个不同的GDF-15类别的研究,以及有关糖尿病患病率的数据.
- 使用元回归来探索异质性.
主要成果:
- 包括27项研究,56,969名参与者 (12,795名糖尿病患者).
- 较高的GDF-15水平与明显更高的糖尿病患病率相关 (OR 2.53).
- 糖尿病患病率在GDF-15中每增加1ng/mL增加了63%,具有非线性趋势和5.7ng/mL左右的平原.
结论:
- 在循环GDF-15和糖尿病患病率之间存在积极的非线性关联.
- 在较高的GDF-15度下,糖尿病患病率平原或略有下降.
- 异质性受样本大小和高血压患病率的影响.
更多相关视频
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
